Ling Gao

发表

Chronic mTOR activation promotes cell survival in Merkel cell carcinoma.

L. Cornelius, Lijian Shao, B. Stack, 2014, Cancer letters.

Skin cancer viruses: bench to bedside – HPV, HHV8 and Merkel cell carcinoma virus

Ling Gao, M. Hughes, 2013 .

Merkel Cell Carcinoma: Epidemiology, Target, and Therapy

J. Becker, L. Cornelius, L. Hutchins, 2014, Current Dermatology Reports.

Proteasome‐associated autoinflammatory syndromes: advances in pathogeneses, clinical presentations, diagnosis, and management

P. Emanuel, M. Kessler, A. McDermott, 2015, International journal of dermatology.

A Case of Merkel Cell Carcinoma Treated with Anti-CTLA-4 Antibody (Ipilimumab)

L. Hutchins, S. Shalin, M. Hardee, 2015 .

Application of Baricitinib in Dermatology

Yaqi Tan, Ling Gao, Jingya Zhang, 2022, Journal of inflammation research.

CLL/SLL with initial presentation as a longstanding cutaneous plaque: a rare case

S. Shalin, D. Alapat, Ling Gao, 2016, Journal of cutaneous pathology.

A Proteomic Study of Human Merkel Cell Carcinoma

L. Cornelius, A. Tackett, B. Stack, 2013, Journal of proteomics & bioinformatics.

CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma

Xinhua Liu, Wenying Zhong, Ling Gao, 2022, Frontiers in Immunology.

Pyoderma gangrenosum developing after chest tube placement in a patient with chronic lymphocytic leukemia.

Pooja Motwani, H. Wong, J. Kaley, 2019, Cutis.

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies

D. Foell, S. Holland, S. Paul, 2018, The Journal of clinical investigation.

Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production.

E. Remmers, D. Kastner, A. Mégarbané, 2016, Journal of Clinical Investigation.

Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production.

E. Remmers, D. Kastner, A. Mégarbané, 2015, The Journal of clinical investigation.

Inhibition of PI3K by copanlisib exerts potent antitumor effects on Merkel cell carcinoma cell lines and mouse xenografts

B. Fang, S. Ejadi, Q. Nguyen, 2020, Scientific Reports.

Inhibition of PI3K by copanlisib exerts potent antitumor effects on Merkel cell carcinoma cell lines and mouse xenografts

B. Fang, S. Ejadi, Q. Nguyen, 2020, Scientific Reports.

A phase II clinical study of combining FOLFIRI and bevacizumab plus erlotinib in 2nd-line chemotherapy for patients with metastatic colorectal cancer

Baolong Niu, Rui Ye, Xuan Wu, 2017, Medicine.

Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth

B. Stack, E. Vural, B. Fang, 2015, Oncotarget.

Circulating tumor DNA as a predictive biomarker in Merkel cell carcinoma.

G. Daniels, C. Lacy, J. Harris, 2022, Journal of the American Academy of Dermatology.

Erratum: Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type i IFN production (Journal of Clinical Investigation (2015) 125:11 (4196-4211) DOI: 10.1172/JCI81260)

E. Remmers, D. Kastner, A. Mégarbané, 2016 .

Erratum to: Pruritus Reduction with Systemic Anti-lymphoma Treatments in Patients with Cutaneous T Cell Lymphoma: A Narrative Review

Pooja Motwani, H. Wong, Ling Gao, 2016, Dermatology and Therapy.

Pruritus Reduction with Systemic Anti-lymphoma Treatments in Patients with Cutaneous T Cell Lymphoma: A Narrative Review

Pooja Motwani, H. Wong, Ling Gao, 2016, Dermatology and Therapy.

BET protein inhibitor JQ1 attenuates Myc-amplified MCC tumor growth in vivo.

B. Stack, J. Suen, Q. Shao, 2014, Cancer research.

Tumor and Stem Cell Biology BET Protein Inhibitor JQ 1 Attenuates Myc-Ampli fi ed MCC Tumor Growth In Vivo

B. Stack, J. Suen, Q. Shao, 2014 .

Diffuse Tenosynovial Giant Cell Tumor Around the Temporomandibular Joint: An Entity With Special Radiologic and Pathologic Features.

Lijuan Zhang, Jihua Liu, Ling Gao, 2019, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

A prognostic analysis of primitive neuroectodermal tumor for postoperative recurrent patients and a literature review

Rui Ye, L. Qiu, Xuan Wu, 2016 .

Simultaneously targeting DNA damage repair pathway and mTORC1/2 results in small cell lung cancer growth arrest via ER stress-induced apoptosis

T. Guo, B. Fang, A. Kannan, 2018, International journal of biological sciences.

Interleukin-6 as a potential molecular target in esophageal squamous cell carcinoma

Baolong Niu, Rui Ye, Xuan Wu, 2015, Oncology letters.

Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma

Alan J Tackett, A. Tackett, B. Stack, 2015, Epigenetics.

Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma.

F. Mahmoud, Ling Gao, M. Shiver, 2015, The New England journal of medicine.

A case of proteasome-associated auto-inflammatory syndrome with compound heterozygous mutations.

P. Emanuel, Yin Liu, R. Goldbach-Mansky, 2013, Journal of the American Academy of Dermatology.

Loss of cytokeratin 20 and acquisition of thyroid transcription factor-1 expression in a merkel cell carcinoma metastasis to the brain.

J. Suen, S. Shalin, Christopher P. Cifarelli, 2014, The American Journal of dermatopathology.